Mesenchymal Stem Cells

Considering the Therapeutic Treatment Potential of Mesenchymal Stem Cells in the Treatment of Glaucoma

Glaucoma is a complex group of interrelated eye conditions that affects over 70 million people worldwide.  A leading cause of irreversible blindness in people over 60, glaucoma is a progressive condition that affects the optic nerve and leads to gradual loss of specific neurons that relay visual information from the retina to the brain; the…

A Review of Safety and Clinical Effects of Neurotrophic Factor Transplantation in Patients with Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease or Lou Gehrig’s disease, is a disease that gradually paralyzes people because the brain is no longer able to communicate with the muscles of the body that we are typically able to move at will[1]; as ALS progresses, people will lose the ability to walk,…

Exploring the Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells in Patients with Heart Failure

After a decade of research, the safety and efficacy of intravenous infusion of bone-marrow-derived stem cells for therapeutic treatment in individuals with heart failure have been well established; however, until Bartolucci et al’s phase 1 / 2 randomized controlled trial of intravenous infusion umbilical cord mesenchymal stem cells (UC-MSCs) on heart disease, no clinical studies…

Exploring the Past, Present, and Future Treatment of Multiple System Atrophy

Multiple system atrophy (MSA) is a rare, progressively degenerative neurological disorder that affects several of the central nervous system’s involuntary (autonomic) functions, including blood pressure, breathing, bladder function, and motor control. Similar to Parkinson’s disease in both symptoms and progression, MSA has an average survival time of 7-9 years with no known treatment; the condition…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.